首页> 外文期刊>European Journal of Pharmacology: An International Journal >Nicotine's central cardiovascular actions: receptor subtypes involved and their possible physiological role in anaesthetized rats.
【24h】

Nicotine's central cardiovascular actions: receptor subtypes involved and their possible physiological role in anaesthetized rats.

机译:尼古丁的中枢心血管作用:参与的受体亚型及其在麻醉大鼠中的可能生理作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Centrally applied nicotine causes changes in blood pressure and vasopressin release. The involvement of different neuronal nicotinic receptor subtypes in these actions was investigated in anaesthetized rats. Nicotine administered i.c.v. caused a dose-related increase in blood pressure and renal sympathoinhibition, while i.c. administration also caused a bradycardia. In the presence of the V(1A) receptor antagonist (i.v.), nicotine (i.c) now caused a depressor response along with sympathoinhibition and bradycardia. Nicotine (0.3 mumol/kg; i.c.v.) in the presence of the alpha4beta2 receptor antagonist, dihydro-beta-erythroidine, (i.c.v.) evoked renal sympathoexcitation, while the alpha7 receptor antagonist, methyllycaconitine, delayed the expected sympathoinhibition. Both receptor antagonists blocked the pressor response. Dihydro-beta-erythroidine (i.c., 10mumol/kg) alone caused a transient pressor response and increased renal nerve activity. Methyllycaconitine (i.c., 0.1 mumol/kg) alone caused a slow fall in blood pressure and renal nerve activity, while the higher doses caused a pressor response and increased renal nerve activity. It was concluded that for nicotine to release vasopressin, activation of both alpha4beta2 and alpha7 receptors is required. The ability of nicotine to cause sympathoinhibition is mediated by beta4*-containing receptors, possibly alpha3beta4 receptors, and that activation of these receptors can override the sympathoexcitatory action of alpha4beta2 and alpha7 receptors. The ability of dihydro-beta-erythroidine and high doses of methyllycaconitine i.c. to cause sympathoexcitation and a pressor response is due to receptor antagonists blocking these sympathoinhibitory beta4*-containing receptors, which receive a tonic cholinergic input. As the low dose of methyllycaconitine caused sympathoinhibition, this indicates that sympathoexcitatory alpha7 receptors also receive a tonic input.
机译:集中施用尼古丁会引起血压变化和加压素释放。在麻醉的大鼠中研究了不同神经元烟碱样受体亚型参与这些作用。尼古丁静脉内给药引起血压和肾交感神经抑制的剂量相关升高,而i.c.给药还引起心动过缓。在存在V(1A)受体拮抗剂(i.v.)的情况下,尼古丁(i.c)现在引起了交感抑制和心动过缓以及抑郁反应。尼古丁(0.3μmol/ kg; i.c.v.)在存在alpha4beta2受体拮抗剂dihydro-beta-erythroidine(i.c.v.)时引起肾脏交感神经兴奋,而α7受体拮抗剂甲基lycaconitine延迟了预期的交感神经抑制作用。两种受体拮抗剂均阻断了升压反应。单独的二氢-β-类赤藓碱(即10μmol/ kg)引起短暂的升压反应并增加肾神经活动。单独的甲基降糖康定(i.c.,0.1μmol/ kg)会导致血压和肾神经活动的缓慢下降,而更高的剂量会引起升压反应并增加肾神经的活动。得出的结论是,要使尼古丁释放血管加压素,就需要激活alpha4beta2和alpha7受体。尼古丁引起交感神经抑制的能力是由含beta4 *的受体(可能是alpha3beta4受体)介导的,这些受体的激活可以取代alpha4beta2和alpha7受体的交感兴奋作用。二氢-β-类胡萝卜素的能力和大剂量的甲基卡卡尼碱的腹腔注射引起交感神经兴奋和升压反应的原因是受体拮抗剂阻断了这些含有β4*的交感神经抑制受体,这些受体接受了滋补胆碱能的输入。由于低剂量的甲基lycaconitine引起交感神经抑制,这表明交感神经兴奋性α7受体也接受补品输入。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号